Actively Recruiting

Age: 6Months - 18Years
All Genders
Healthy Volunteers
NCT02496468

Pediatric Arm of DZL All Age Asthma Cohort

Led by LMU Klinikum · Updated on 2024-08-28

1500

Participants Needed

5

Research Sites

778 weeks

Total Duration

On this page

Sponsors

L

LMU Klinikum

Lead Sponsor

G

German Federal Ministry of Education and Research

Collaborating Sponsor

AI-Summary

What this Trial Is About

Despite its common occurrence, still little is known about pathomechanisms determining different wheeze and asthma trajectories and phenotypes in children, and those beginning in adulthood. Therefore, deciphering underlying determinants for different childhood and adult asthma phenotypes is urgently needed to develop personalized treatment approaches targeting distinct underlying mechanisms. Thereby, secondary prevention early in the disease process can also be achieved. The decoding of such mechanisms and their translation to the individual patient is the aim of the Disease Area Asthma Allergy of the 'German Centre for Lung Research' (DZL).

CONDITIONS

Official Title

Pediatric Arm of DZL All Age Asthma Cohort

Who Can Participate

Age: 6Months - 18Years
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Informed consent by parents (and by children if age > 8 years)
  • Age between 6 months and 18 years
  • Born at term (at least 37 weeks gestation)
  • Active or passive understanding of German
  • For children 6 months to under 6 years: more than two episodes of wheeze in the past 12 months
  • For children 6 years and older: doctor-diagnosed asthma according to current guidelines
Not Eligible

You will not qualify if you...

  • Known inborn or perinatal lung disease
  • Airway malformation
  • Oxygen therapy after birth lasting more than 24 hours
  • Ventilator support or mechanical ventilation after birth
  • Diagnosis of cystic fibrosis or primary ciliary dyskinesia
  • Heart failure diagnosed after birth affecting lung circulation
  • Major respiratory diseases such as interstitial lung disease
  • Any current non-atopic comorbidity
  • Fever of at least 38.5°C (101.3°F) in the two weeks before the first visit

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 5 locations

1

University Children's Hospital Cologne, Department of Paediatric Allergology and Pneumology

Cologne, Germany, 50937

Actively Recruiting

2

Medizinische Hochschule Hannover, Biomedical Research in Endstage and Obstructive Lung Disease

Hanover, Germany, 30625

Actively Recruiting

3

Universitaetsklinikum Schleswig-Holstein, Klinik für Kinder- und Jugendmedizin, Airway Research Center North

Lübeck, Germany, 23528

Actively Recruiting

4

Klinik für Kinder- und Jugendmedizin, Universitaetsklinikum Giessen und Marburg GmbH, Universities of Giessen and Marburg Lung Center

Marburg, Germany, 35033

Actively Recruiting

5

Klinikum der Universitaet Muenchen, Comprehensive Pulmonary Center Munich

Munich, Germany, 80337

Actively Recruiting

Loading map...

Research Team

E

Esther Zeitlmann, Diplom

CONTACT

B

Bianca Schaub, MD

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

3

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here